NIAGEN BIOSCIENCE INC (NAGE) Stock Cash Flow
USA - NASDAQ:NAGE - US1710774076 - Common Stock
9.62 USD
+0.02 (+0.21%)
9.6 USD
-0.02 (-0.21%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 17.73M | 8.55M | -4.94M | -16.54M | -27.13M | |||
| Depreciation Amortization | 782.00K | 814.00K | 1.03M | 1.06M | 1.12M | |||
| Change In Working Capital | 3.99M | 3.13M | 4.56M | -6.32M | -5.01M | |||
| Interest Paid | N/A | 1.00K | 2.00K | 0.00 | 0.00 | |||
| Other non cash items | -1.29M | -389.00K | 6.46M | 6.71M | 6.86M | |||
| OPERATING CASH FLOW | 21.21M | 12.11M | 7.12M | -15.10M | -24.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -277.00K | -163.00K | -148.00K | -330.00K | -410.00K | |||
| Other Investing Activity | N/A | 20.00K | 5.00K | N/A | 0.00 | |||
| INVESTING CASH FLOW | -257.00K | -143.00K | -143.00K | -330.00K | -410.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -12.00K | -11.00K | -15.00K | -20.00K | -30.00K | |||
| Stock Issued/Repurchased | 11.70M | 5.43M | 0.00 | 7.75M | 36.24M | |||
| Other Financing Activity | -53.00K | -52.00K | -75.00K | -80.00K | -110.00K | |||
| FINANCING CASH FLOW | 11.63M | 5.37M | -90.00K | 7.65M | 36.09M | |||
| CHANGE IN CASH | 32.59M | 17.34M | 6.88M | -7.78M | 11.52M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 21.21M | 12.11M | 7.12M | -15.10M | -24.16M | |||
| Capital Expenditure | -277.00K | -163.00K | -148.00K | -330.00K | -410.00K | |||
| FREE CASH FLOW | 20.93M | 11.95M | 6.97M | -15.43M | -24.57M | |||
All data in USD